{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:20:58Z","timestamp":1780500058729,"version":"3.54.1"},"reference-count":59,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Increased dehydroepiandrosterone sulfate (DHEAS) is used as a diagnostic marker of hyperandrogenism in women with polycystic ovary syndrome (PCOS). The mechanisms of adrenal hyperandrogenism in PCOS include hyperinsulinism as a potential stimulator, but results of studies associating insulinemia with DHEAS in PCOS are conflicting. The objective of this study was to evaluate the factors associated with DHEAS levels in PCOS, focusing on insulinemia. Methods: We performed a cross-sectional retrospective study in a total of 257 patients with PCOS (Rotterdam criteria) evaluated in our tertiary center of endocrinology. Clinical and biochemical parameters included body mass index (BMI), serum DHEAS, total testosterone and sex hormone-binding globulin (SHBG), insulin and glycaemia at fasting and 2 h during the oral glucose tolerance test (OGTT), and homeostasis model assessment for insulin resistance (HOMA-IR) was calculated. Results: The comparative analysis of PCOS divided into DHEAS tertiles revealed that patients in the upper tertile were younger (p &lt; 0.05) and had higher 2 h insulin in the OGTT (p &lt; 0.05) than the lower tertile, while fasting insulin and HOMA-IR were not different. DHEAS correlated negatively with age (r = \u22120.146, p &lt; 0.05) and positively with 2 h insulinemia (r = 0.246, p &lt; 0.001), while fasting insulin and HOMA-IR did not correlate with DHEAS in all PCOS. In stepwise linear regression models, 2 h insulin remained a positive independent predictor for DHEAS only in non-obese PCOS (p &lt; 0.0001). Conclusions: Our data indicate a positive association between stimulated insulin and DHEAS in PCOS. Two-hour insulin in OGTT was an independent predictor of DHEAS in non-obese PCOS, suggesting that DHEAS might be a reliable marker for the stimulatory insulin effect on adrenal steroidogenesis in non-obese PCOS patients.<\/jats:p>","DOI":"10.3390\/jcm14176246","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T10:55:37Z","timestamp":1756983337000},"page":"6246","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Stimulated Hyperinsulinemia Is Independently Associated with Higher Serum DHEAS in PCOS: A Retrospective Study"],"prefix":"10.3390","volume":"14","author":[{"given":"Nicoleta","family":"Baculescu","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"First Endocrinology Department, C.I. Parhon National Institute of Endocrinology, 011863 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6488-4242","authenticated-orcid":false,"given":"Serban","family":"Radian","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"First Endocrinology Department, C.I. Parhon National Institute of Endocrinology, 011863 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Manda","sequence":"additional","affiliation":[{"name":"Molecular Cellular and Structural Endocrinology Laboratory, C.I. Parhon National Institute of Endocrinology, 011863 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Georgiana","family":"Serban","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan Alexandru","family":"Niculescu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"First Endocrinology Department, C.I. Parhon National Institute of Endocrinology, 011863 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1754-5619","authenticated-orcid":false,"given":"Monica Livia","family":"Gheorghiu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"First Endocrinology Department, C.I. Parhon National Institute of Endocrinology, 011863 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florin","family":"Grigorescu","sequence":"additional","affiliation":[{"name":"Institut Convergences Migrations, Coll\u00e8ge de France, 93322 Paris-Aubervilliers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Poiana","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania"},{"name":"First Endocrinology Department, C.I. Parhon National Institute of Endocrinology, 011863 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1210\/endrev\/bnac001","article-title":"Deconstructing a Syndrome: Genomic Insights into PCOS Causal Mechanisms and Classification","volume":"43","author":"Dapas","year":"2022","journal-title":"Endocr. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0015-0282(16)55152-8","article-title":"The Ratio of Androstenedione:11 Beta-Hydroxyandrostenedione Is an Important Marker of Adrenal Androgen Excess in Women","volume":"58","author":"Carmina","year":"1992","journal-title":"Fertil. Steril."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1507\/endocrj.EJ18-0212","article-title":"11-Oxygenated C19 Steroids as Circulating Androgens in Women with Polycystic Ovary Syndrome","volume":"65","author":"Yoshida","year":"2018","journal-title":"Endocr. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e2047","DOI":"10.1210\/clinem\/dgab920","article-title":"Clinical Value of Serum Levels of 11-Oxygenated Metabolites of Testosterone in Women With Polycystic Ovary Syndrome","volume":"107","author":"Tosi","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2042018820934319","DOI":"10.1177\/2042018820934319","article-title":"Implicating Androgen Excess in Propagating Metabolic Disease in Polycystic Ovary Syndrome","volume":"11","author":"Kempegowda","year":"2020","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1210\/jc.2016-3285","article-title":"11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome","volume":"102","author":"Kempegowda","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_7","first-page":"2611","article-title":"Newly Proposed Hormonal Criteria via Genotypic Proof for Type II 3beta-Hydroxysteroid Dehydrogenase Deficiency","volume":"87","author":"Lutfallah","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_8","unstructured":"Azziz, R., Nestler, J.E., and Dewaill, D. (1997). Abnormalities of Adrenocortical Steroidogenesis in PCOS. Androgen Excess Disorders in Women, Lippincott-Raven."},{"key":"ref_9","first-page":"2317","article-title":"Adrenal Androgen Excess in the Polycystic Ovary Syndrome: Sensitivity and Responsivity of the Hypothalamic-Pituitary-Adrenal Axis","volume":"83","author":"Azziz","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jsbmb.2014.06.003","article-title":"DHEA, DHEAS and PCOS","volume":"145","author":"Goodarzi","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1530\/acta.0.1040110","article-title":"Insulin Resistance in Patients with Polycystic Ovaries: Its Relationship to Body Weight and Androgen Levels","volume":"104","author":"Pasquali","year":"1983","journal-title":"Eur. J. Endocrinol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.fertnstert.2008.02.101","article-title":"Dehydroepiandrosterone Sulfate and Insulin Resistance in Patients with Polycystic Ovary Syndrome","volume":"91","author":"Brennan","year":"2009","journal-title":"Fertil. Steril."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.fertnstert.2005.09.046","article-title":"Hyperinsulinemia and Circulating Dehydroepiandrosterone Sulfate in White and Mexican American Women with Polycystic Ovary Syndrome","volume":"85","author":"Kauffman","year":"2006","journal-title":"Fertil. Steril."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.fertnstert.2014.12.105","article-title":"Influence of Adrenal Hyperandrogenism on the Clinical and Metabolic Phenotype of Women with Polycystic Ovary Syndrome","volume":"103","year":"2015","journal-title":"Fertil. Steril."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0015-0282(16)55220-0","article-title":"Differential Androgen Response to Adrenocorticotropic Hormone Stimulation in Polycystic Ovarian Syndrome: Relationship with Insulin Secretion","volume":"58","author":"Lanzone","year":"1992","journal-title":"Fertil. Steril."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/0002-9378(95)91488-9","article-title":"Chronic Hyperinsulinemia and the Adrenal Androgen Response to Acute Corticotropin-(1-24) Stimulation in Hyperandrogenic Women","volume":"172","author":"Azziz","year":"1995","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_17","first-page":"881","article-title":"Insulin Infusion Amplifies 17 Alpha-Hydroxycorticosteroid Intermediates Response to Adrenocorticotropin in Hyperandrogenic Women: Apparent Relative Impairment of 17,20-Lyase Activity","volume":"81","author":"Moghetti","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1530\/EJE-10-0782","article-title":"Insulin Enhances ACTH-Stimulated Androgen and Glucocorticoid Metabolism in Hyperandrogenic Women","volume":"164","author":"Tosi","year":"2011","journal-title":"Eur. J. Endocrinol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0015-0282(16)54172-7","article-title":"Androgen Responses to Acutely Increased Endogenous Insulin Levels in Hyperandrogenic and Normal Cycling Women","volume":"55","author":"Valdes","year":"1991","journal-title":"Fertil. Steril."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0015-0282(16)54738-4","article-title":"No Acute Effect of Physiological Insulin Increase on Dehydroepiandrosterone Sulfate in Women with Obesity and\/or Polycystic Ovarian Disease","volume":"56","author":"Buyalos","year":"1991","journal-title":"Fertil. Steril."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/humrep\/12.6.1138","article-title":"Impact of Overnight Dexamethasone Suppression on the Adrenal Androgen Response to an Oral Glucose Tolerance Test in Women with and without Polycystic Ovary Syndrome","volume":"12","author":"Buyalos","year":"1997","journal-title":"Hum. Reprod."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1210\/jcem-71-6-1653","article-title":"Androgen Response to Endogenous Insulin Secretion during the Frequently Sampled Intravenous Glucose Tolerance Test in Normal and Hyperandrogenic Women","volume":"71","author":"Falcone","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1043-2760(02)00609-4","article-title":"Dissecting Human Adrenal Androgen Production","volume":"13","author":"Rainey","year":"2002","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.beem.2006.03.007","article-title":"Diagnosis of Hyperandrogenism: Biochemical Criteria","volume":"20","author":"Stanczyk","year":"2006","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group (2004). Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome (PCOS). Hum. Reprod., 19, 41\u201347.","DOI":"10.1093\/humrep\/deh098"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical Assessment of Body Hair Growth in Women","volume":"21","author":"Ferriman","year":"1961","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic Ovary Syndrome: Etiology, Pathogenesis and Diagnosis","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen Excess in Women: Experience with over 1000 Consecutive Patients","volume":"89","author":"Azziz","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2337\/diab.43.2.247","article-title":"Prevalence of Mutations in the Insulin Receptor Gene in Subjects with Features of the Type A Syndrome of Insulin Resistance","volume":"43","author":"Moller","year":"1994","journal-title":"Diabetes"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1210\/jc.2005-1457","article-title":"Extensive Clinical Experience: Relative Prevalence of Different Androgen Excess Disorders in 950 Women Referred Because of Clinical Hyperandrogenism","volume":"91","author":"Carmina","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis Model Assessment: Insulin Resistance and Beta-Cell Function from Fasting Plasma Glucose and Insulin Concentrations in Man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0015-0282(16)45254-4","article-title":"Plasma Androgens and Sex Hormone-Binding Globulin in the Evaluation of Hirsute Females","volume":"35","author":"Mathur","year":"1981","journal-title":"Fertil. Steril."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.fertnstert.2008.05.076","article-title":"Effect of Insulin and Testosterone on Androgen Production and Transcription of SULT2A1 in the NCI-H295R Adrenocortical Cell Line","volume":"92","author":"Kumar","year":"2009","journal-title":"Fertil. Steril."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1530\/EJE-14-0600","article-title":"Visceral Adiposity Index and DHEAS Are Useful Markers of Diabetes Risk in Women with Polycystic Ovary Syndrome","volume":"172","author":"Amato","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1210\/jc.2009-0427","article-title":"Adrenal Function during Childhood and Puberty in Daughters of Women with Polycystic Ovary Syndrome","volume":"94","author":"Maliqueo","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jcem.87.4.8398","article-title":"Metformin Therapy in Obese Adolescents with Polycystic Ovary Syndrome and Impaired Glucose Tolerance: Amelioration of Exaggerated Adrenal Response to Adrenocorticotropin with Reduction of Insulinemia\/Insulin Resistance","volume":"87","author":"Arslanian","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0015-0282(02)04914-2","article-title":"Troglitazone Decreases Adrenal Androgen Levels in Women with Polycystic Ovary Syndrome","volume":"79","author":"Azziz","year":"2003","journal-title":"Fertil. Steril."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.fertnstert.2006.11.076","article-title":"Pioglitazone Reduces the Adrenal Androgen Response to Corticotropin-Releasing Factor without Changes in ACTH Release in Hyperinsulinemic Women with Polycystic Ovary Syndrome","volume":"88","author":"Romualdi","year":"2007","journal-title":"Fertil. Steril."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000134831","article-title":"Fetal Programming of Adrenal Androgen Excess: Lessons from a Nonhuman Primate Model of Polycystic Ovary Syndrome","volume":"13","author":"Abbott","year":"2008","journal-title":"Endocr. Dev."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11154-007-9054-0","article-title":"The Adrenal and Polycystic Ovary Syndrome","volume":"8","author":"Yildiz","year":"2007","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0015-0282(98)00033-8","article-title":"Role of the Ovary in the Adrenal Androgen Excess of Hyperandrogenic Women","volume":"69","author":"Azziz","year":"1998","journal-title":"Fertil. Steril."},{"key":"ref_43","first-page":"3892","article-title":"Insulin-like Growth Factors Enhance Steroidogenic Enzyme and Corticotropin Receptor Messenger Ribonucleic Acid Levels and Corticotropin Steroidogenic Responsiveness in Cultured Human Adrenocortical Cells","volume":"81","author":"Penhoat","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"10619","DOI":"10.1073\/pnas.92.23.10619","article-title":"Serine Phosphorylation of Human P450c17 Increases 17,20-Lyase Activity: Implications for Adrenarche and the Polycystic Ovary Syndrome","volume":"92","author":"Zhang","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1210\/clinem\/dgac365","article-title":"Excess 11-Oxygenated Androgens in Women with Severe Insulin Resistance Are Mediated by Adrenal Insulin Receptor Signaling","volume":"107","author":"Walzer","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1210\/en.2003-0329","article-title":"Insulin Augmentation of 17alpha-Hydroxylase Activity Is Mediated by Phosphatidyl Inositol 3-Kinase but Not Extracellular Signal-Regulated Kinase-1\/2 in Human Ovarian Theca Cells","volume":"145","author":"Munir","year":"2004","journal-title":"Endocrinology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0889-8529(05)70074-8","article-title":"Insulin Action in the Normal and Polycystic Ovary","volume":"28","author":"Franks","year":"1999","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1210\/jc.2007-1036","article-title":"Early Metabolic Derangements in Daughters of Women with Polycystic Ovary Syndrome","volume":"92","author":"Maliqueo","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1210\/jcem.87.5.8513","article-title":"Insulin Resistance in the Sisters of Women with Polycystic Ovary Syndrome: Association with Hyperandrogenemia Rather than Menstrual Irregularity","volume":"87","author":"Legro","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1210\/jcem.87.5.8387","article-title":"Elevated Dehydroepiandrosterone Sulfate Levels as the Reproductive Phenotype in the Brothers of Women with Polycystic Ovary Syndrome","volume":"87","author":"Legro","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2337\/dc07-2190","article-title":"Metabolic Phenotype in the Brothers of Women with Polycystic Ovary Syndrome","volume":"31","author":"Sam","year":"2008","journal-title":"Diabetes Care"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1210\/jc.2008-2836","article-title":"Metabolic and Reproductive Features before and during Puberty in Daughters of Women with Polycystic Ovary Syndrome","volume":"94","author":"Codner","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.bbrc.2013.10.002","article-title":"Dehydroepiandrosterone-Sulfate (DHEAS) Promotes MIN6 Cells Insulin Secretion via Inhibition of AMP-Activated Protein Kinase","volume":"440","author":"Yue","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2337\/diab.40.6.693","article-title":"Opposing Actions of Dehydroepiandrosterone and Testosterone on Insulin Sensitivity. In Vivo and In Vitro Studies of Hyperandrogenic Females","volume":"40","author":"Buffington","year":"1991","journal-title":"Diabetes"},{"key":"ref_55","first-page":"923","article-title":"A relationship between dehydroepiandrosterone sulphate and insulin resistance in obese men and women","volume":"50","author":"Mottl","year":"2004","journal-title":"Vnitr. Lek."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/aje\/153.1.79","article-title":"Low Dehydroepiandrosterone and Ischemic Heart Disease in Middle-Aged Men: Prospective Results from the Massachusetts Male Aging Study","volume":"153","author":"Feldman","year":"2001","journal-title":"Am. J. Epidemiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.metabol.2004.12.011","article-title":"Association of Decrease in Serum Dehydroepiandrosterone Sulfate Levels with the Progression to Type 2 Diabetes in Men of a Japanese Population: The Funagata Study","volume":"54","author":"Kameda","year":"2005","journal-title":"Metabolism"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1093\/ejendo\/lvad096","article-title":"Recommendations from the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome","volume":"189","author":"Teede","year":"2023","journal-title":"Eur. J. Endocrinol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1179558119874042","DOI":"10.1177\/1179558119874042","article-title":"Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies","volume":"13","author":"Barber","year":"2019","journal-title":"Clin. Med. Insights Reprod. Health"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/17\/6246\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:39:22Z","timestamp":1760035162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/17\/6246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,4]]},"references-count":59,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["jcm14176246"],"URL":"https:\/\/doi.org\/10.3390\/jcm14176246","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,4]]}}}